Neuropace, Inc. NPCE Disallowed business interest expense carryforward
Disallowed business interest expense carryforward at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetInterestCarryforward.
The official record: Neuropace, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s disallowed business interest expense carryforward.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s disallowed business interest expense carryforward?
- Neuropace, Inc. (NPCE) reported disallowed business interest expense carryforward of $6.71M in Q4 2025.
- How has Neuropace, Inc.'s disallowed business interest expense carryforward changed year-over-year?
- Neuropace, Inc.'s disallowed business interest expense carryforward increased by 16.7% year-over-year, from $5.75M to $6.71M.
- What is the long-term trend for Neuropace, Inc.'s disallowed business interest expense carryforward?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s disallowed business interest expense carryforward has grown at a 40.4% compound annual growth rate (CAGR), from $1.23M to $6.71M.